Most troublesome quality of life concerns in patients with brain metastases: baseline results from the phase III trial with motexafin gadolinium Article

cited authors

  • Rodrigus, P; Mehta, MP; Dehnad, H; Rao, A; Suh, J; Roa, W; Souhami, L; Bezjak, A; Leibenhaut, M; Komaki, R; Schultz, CJ; Timmerman, R; Illidge, T; Curran, WJ; Phan, SC; Smith, J; Renschler, MF

fiu authors

publication date

  • November 1, 2001

Digital Object Identifier (DOI)

start page

  • 410


  • 51


  • 3